Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Current Deferred Revenue (2016 - 2025)

Mesa Laboratories' Current Deferred Revenue history spans 13 years, with the latest figure at $14.6 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 1.03% year-over-year to $14.6 million; the TTM value through Dec 2025 reached $14.6 million, down 1.03%, while the annual FY2025 figure was $14.8 million, 5.63% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $14.6 million at Mesa Laboratories, up from $14.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $16.3 million in Q3 2022 and bottomed at $8.9 million in Q2 2021.
  • The 5-year median for Current Deferred Revenue is $14.6 million (2022), against an average of $14.0 million.
  • The largest annual shift saw Current Deferred Revenue soared 70.76% in 2022 before it fell 10.04% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $12.5 million in 2021, then grew by 16.83% to $14.6 million in 2022, then fell by 1.56% to $14.4 million in 2023, then increased by 2.46% to $14.7 million in 2024, then fell by 1.03% to $14.6 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Current Deferred Revenue are $14.6 million (Q4 2025), $14.3 million (Q3 2025), and $15.1 million (Q2 2025).